ㅤSeoul, South Korea — 15th Oct 2025
SM DERMA is strengthening its foothold in the European market by registering its Lumiderm Rx product with the Cosmetic Products Notification Portal (CPNP) of the European Union. The CPNP registration process is a mandatory step for all cosmetic products seeking entry into the EU market. Through this certification, SM DERMA aims to ensure regulatory compliance, secure stable distribution channels, and reinforce its credibility among European distributors and consumers. “Completing the CPNP registration is a vital milestone for us,” SM DERMA CEO HEECHAN LEE stated. “It not only demonstrates our commitment to meeting international standards but also supports our long-term vision of becoming a trusted global brand in the aesthetic dermatology sector.” As the company proceeds with the registration process, SM DERMA anticipates that its Lumiderm Rx product will soon be available across key European markets. The ongoing CPNP registration underscores SM DERMA’s dedication to product safety, transparency, and sustained growth in the global cosmetics industry.